Alva Chen

Managing Director
VMS Group

​

Dr. Alva Chen has over 15 years of experience in academia, strategy consulting, and healthcare investments. She is currently the Managing Director and Head of Therapeutics at VMS Group, a Hong Kong-based multi-strategy financial group with around US$10 billion in assets under management, providing specialized investment solutions and consulting services. Prior to VMS, Dr. Chen was a healthcare consultant at the Economist Intelligence Unit (EIU), a strategy consulting subsidiary of the Economist Group, advising global pharmaceutical giants, medical technology, and IVD companies on their APAC and ASEAN strategies.
 
Dr. Chen has honed her exceptional technical skills through hands-on research and discovery experience. She worked as a postdoctoral scientist at the University of Cambridge, where she published several papers and reviews in high-impact scientific journals, including Nature Genetics and Brain. Dr Chen also worked as visiting scientist at Pfizer UK, her collaboration work with Pfizer identified a novel drug target and contributed to the industry advancement. Dr. Chen was awarded the prestigious LPC Wellcome Trust Strategic Award studentship for her PhD and earned her PhD in Molecular and Cellular Biology. She also holds a BSc in Biochemistry from Imperial College London, UK.

 

Speech title & Synopsis

Panel Discussion 1: Business Development & Licensing - Critical Exit Strategy for New Venture

Panelist